The Bloody Crossroads: Interactions between Periodontitis and Hematologic Diseases. [PDF]
Int J Mol SciPeriodontitis is a common oral condition that can have a significant impact on the overall health of the body. In recent years, attention has been paid to potential relationships between periodontitis and various hematological disorders. This publication
Łobacz M +7 more
europepmc +4 more sources
COVID-19 in Patients with Hematologic Diseases. [PDF]
Biomedicines, 2022 The COVID-19 outbreak had a strong impact on people’s lives all over the world. Patients with hematologic diseases have been heavily affected by the pandemic, because their immune system may be compromised due to anti-cancer or immunosuppressive ...
Casetti IC, Borsani O, Rumi E.
europepmc +2 more sources
Invasive Fusariosis in Patients with Hematologic Diseases. [PDF]
J Fungi (Basel), 2021 Fusarium species are filamentous fungi widely encountered in nature, and may cause invasive disease in patients with hematologic conditions. Patients at higher risk are those with acute leukemia receiving induction remission chemotherapy or allogeneic ...
Nucci M +4 more
europepmc +2 more sources
Bloodstream Infections in Patients with Hematologic Diseases: Causative Organisms and Factors Associated with Resistance. [PDF]
Infect Chemother, 2022 Background Patients with hematologic diseases are at high risk of bloodstream infections (BSIs). This study aimed to analyze clinical features and distributions of microorganisms in patients with hematologic diseases presenting at a tertiary care ...
Choi H, Ahn H, Lee R, Cho SY, Lee DG.
europepmc +2 more sources
Advances in prophylaxis and treatment of invasive fungal infections: perspectives on hematologic diseases. [PDF]
Blood Res, 2022 Invasive fungal infections (IFIs) are common causes of mortality and morbidity in patients with hematologic diseases. Delayed initiation of antifungal treatment is related to mortality. Aspergillus sp.
Ahn H, Lee R, Cho SY, Lee DG.
europepmc +2 more sources
KSHV/HHV8-mediated hematologic diseases.
Blood, 2022 The Kaposi sarcoma herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8), is the causal agent of Kaposi sarcoma (KS), but is also pathogenetically related to several lymphoproliferative disorders, including primary effusion lymphoma (PEL)/extra ...
Cesarman E, Chadburn A, Rubinstein PG.
europepmc +2 more sources
Immune Response after 2 Doses of BNT162b2 mRNA COVID-19 Vaccinations in Children and Adolescents with Cancer and Hematologic Diseases. [PDF]
Asian Pac J Cancer Prev, 2022 Background: The BNT162b2 mRNA COVID-19 vaccine has been administered to children and adolescents with cancer and hematologic diseases since they are at high risk of manifesting severe symptoms if they have COVID-19 infection but the adequate immune ...
Poparn H +7 more
europepmc +2 more sources
Fatal hemorrhagic pneumonia in patients with hematologic diseases and Stenotrophomonas maltophilia bacteremia: a retrospective study. [PDF]
BMC Infect Dis, 2021 Background Fatal hemorrhagic pneumonia is one of the most severe manifestations of Stenotrophomonas maltophilia (SM) infections. Here, we aimed to investigate the clinical characteristics of SM bacteremia and to identify the risk factors of hemorrhagic ...
Zhu L +18 more
europepmc +2 more sources
Hyponatremia in Patients with Hematologic Diseases. [PDF]
J Clin Med, 2020 Hyponatremia is the most common electrolyte disorder in clinical practice and is associated with increased morbidity and mortality. It is frequently encountered in hematologic patients with either benign or malignant diseases.
Koumpis E +3 more
europepmc +2 more sources
Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond.
Blood, 2021 Complement is an elaborate system of the innate immunity. Genetic variants and autoantibodies leading to excessive complement activation are implicated in a variety of human diseases.
E. Gavriilaki +2 more
semanticscholar +1 more source